Ptc Therapeutics (PTCT) Gross Profit Growth (1y) (2017 - 2026)
Ptc Therapeutics (PTCT) Gross Profit Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 41.37% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.76% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 16.94% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 66.01% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ptc Therapeutics | 6.34 Bn | 4.45 Bn | 244.52 Mn | -78.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.98% |
| Dec 31, 2025 | -19.89% |
| Sep 30, 2025 | 5.00% |
| Jun 30, 2025 | 1,178.48% |
| Mar 31, 2025 | 495.38% |
| Dec 31, 2024 | -29.16% |
| Sep 30, 2024 | -0.61% |
| Jun 30, 2024 | -107.72% |
| Mar 31, 2024 | -5.27% |
| Dec 31, 2023 | 77.57% |
| Sep 30, 2023 | -7.89% |
| Jun 30, 2023 | 28.99% |
| Mar 31, 2023 | 48.80% |
| Dec 31, 2022 | 0.40% |
| Sep 30, 2022 | 53.64% |
| Jun 30, 2022 | 42.60% |
| Mar 31, 2022 | 27.35% |
| Dec 31, 2021 | 52.29% |
| Sep 30, 2021 | 16.24% |
| Jun 30, 2021 | 56.31% |